Affordable Access

Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

Authors
  • Coyne, Daniel
  • Acharya, Muralidhar
  • Qiu, Ping
  • Abboud, Hanna
  • Batlle, Daniel
  • Rosansky, Steven
  • Fadem, Stephen
  • Levine, Barton
  • Williams, Laura
  • Andress, Dennis L
  • Sprague, Stuart M
Type
Published Article
Journal
American Journal of Kidney Diseases
Publisher
Elsevier
Publication Date
Feb 01, 2006
Volume
47
Issue
2
Pages
263–276
Identifiers
PMID: 16431255
Source
Medline
License
Unknown

Abstract

Paricalcitol capsule was well tolerated and effectively decreased iPTH levels with minimal or no impact on calcium levels, phosphorus balance, and kidney function in patients with stages 3 and 4 CKD.

Report this publication

Statistics

Seen <100 times